These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7875168)

  • 1. Artificial neural networks that use single-photon emission tomography to identify patients with probable Alzheimer's disease.
    Dawson MR; Dobbs A; Hooper HR; McEwan AJ; Triscott J; Cooney J
    Eur J Nucl Med; 1994 Dec; 21(12):1303-11. PubMed ID: 7875168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.
    Claus JJ; van Harskamp F; Breteler MM; Krenning EP; van der Cammen TJ; Hofman A; Hasan D
    Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).
    Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG
    Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
    Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of neural networks in brain SPECT to diagnose Alzheimer's disease.
    Page MP; Howard RJ; O'Brien JT; Buxton-Thomas MS; Pickering AD
    J Nucl Med; 1996 Feb; 37(2):195-200. PubMed ID: 8667044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semi-automatic quantification of regional cerebral perfusion in primary degenerative dementia using 99m technetium-hexamethylpropylene amine oxime and single photon emission tomography.
    Goulding P; Burjan A; Smith R; Lawson R; Snowden J; Northen B; Neary D; Testa H
    Eur J Nucl Med; 1990; 17(1-2):77-82. PubMed ID: 2083546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single photon emission computed tomography using 99Tcm-HMPAO in Alzheimer's disease.
    Liu HC; Liu RS; Lin KN; Wang SJ; Fuh JL; Yeh SH; Chiang BN
    Nucl Med Commun; 1992 Jul; 13(7):535-41. PubMed ID: 1495679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural-network-based classification of cognitively normal, demented, Alzheimer disease and vascular dementia from single photon emission with computed tomography image data from brain.
    deFigueiredo RJ; Shankle WR; Maccato A; Dick MB; Mundkur P; Mena I; Cotman CW
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5530-4. PubMed ID: 7777543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia.
    Habert MO; Spampinato U; Mas JL; Piketty ML; Bourdel MC; de Recondo J; Rondot P; Askienazy S
    Eur J Nucl Med; 1991; 18(1):3-11. PubMed ID: 2019279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional neuroimaging in Alzheimer's disease: how far should we go?
    Kerwin R
    Eur J Nucl Med; 1994 Oct; 21(10):1041-3. PubMed ID: 7828612
    [No Abstract]   [Full Text] [Related]  

  • 13. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study.
    Claus JJ; van Harskamp F; Breteler MM; Krenning EP; de Koning I; van der Cammen TJ; Hofman A; Hasan D
    Neurology; 1994 Mar; 44(3 Pt 1):454-61. PubMed ID: 8145915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease in Down's syndrome with SPECT.
    Rae-Grant AD; Barbour PJ; Sirotta P; Gross P
    Clin Nucl Med; 1991 Jul; 16(7):509-10. PubMed ID: 1834388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cerebral blood flow study with 99mTc-hexamethyl-propyleneamine oxime single photon emission computed tomography in Alzheimer's and multi-infarct dementia.
    Battistin L; Pizzolato G; Dam M; Ponza I; Borsato N; Zanco PL; Ferlin G
    Eur Neurol; 1990; 30(5):296-301. PubMed ID: 2269322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m hexamethylpropylene amine oxime single photon emission tomography in febrile convulsions.
    Dierckx RA; Melis K; Dom L; Janssens G; Luysterborgh E; De Deyn PP; Vandevivere J
    Eur J Nucl Med; 1992; 19(4):278-82. PubMed ID: 1597244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.
    Davis K
    J Nucl Med; 1992 Feb; 33(2):312. PubMed ID: 1732462
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of brain single photon emission tomography (SPET) using transmission data acquisition in a four-head SPET scanner.
    Murase K; Tanada S; Inoue T; Sugawara Y; Hamamoto K
    Eur J Nucl Med; 1993 Jan; 20(1):32-8. PubMed ID: 8420780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease.
    Koulibaly PM; Nobili F; Migneco O; Vitali P; Robert PH; Girtler N; Darcourt J; Rodriguez G
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1009-13. PubMed ID: 12750851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT.
    Karbe H; Kertesz A; Davis J; Kemp BJ; Prato FS; Nicholson RL
    Neuroradiology; 1994; 36(1):1-6. PubMed ID: 8107986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.